NCT06634589 · Interventional trial
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Overall registry status Recruiting
Phase 1 · Phase 2
Conditions B-cell Lymphoma, B-cell Malignancy, Refractory Cancer, Relapsed Cancer
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory